Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TauroLock vs Saline for Primary Prevention of CLABSI in Cancer Patients
NCT02279121Phase 4Completed
- Sponsor
- CHR Metz-Thionville
- Start
- Nov 2014
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of taurolidine citrate in Catheter-related infection (CRI), sponsored by CHR Metz-Thionville. Started Nov 2014; status: completed.
02
Drugs
taurolidine citrate
03
Conditions
Catheter-related infection (CRI)
Beyond the preview
Go deeper on NCT02279121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02279121.